Shikari® (S-ATC) Anti-Cetuximab ELISA

Enzyme immunoassay for the qualitative determination of specific antibodies to  Cetuximab (Erbitux®) in human serum and plasma. 

This kit has been especially developed for the qualitative determination of Cetuximab in serum and plasma samples.

Cetuximab was associated to the development of anti- Cetuximab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug. This might lead to severe complications. The Matriks Biotek SHIKARI® Antibody to Cetuximab ELISA Kit can be efficiently used for monitoring anti- Cetuximab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti- Cetuximab antibodies.. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.

All SHIKARI® ELISA kits are suitable for biosimilar work.